Genetic signatures expose drug susceptibility in breast cancer cells

(Medical University of South Carolina) A genomics approach at the Medical University of South Carolina has unmasked genetic signatures in breast cancer cells that predict their sensitivity to certain drugs. The findings, published in the May 2, 2016 issue of Oncotarget, provide proof of concept for personalized pharmaceutical therapies that target the genes responsible for driving tumor growth.